Convincing health plans to establish a value-based financial model for an intervention — such as a clinical model, care management program, or population health initiative — requires proof that the intervention works. And that proof has to appeal not only to health plan strategy and clinical leaders, but also to their actuaries.

For providers, life sciences companies, or vendors, getting that proof is hard.

Two common methods of judging the effectiveness of clinical efforts don’t meet the mark: